series-b
Stage
2020
Founded
3
Investors
About
CREATE Medicines is a clinical-stage biotech company pioneering RNA-based in vivo CAR immunotherapies. It reprograms immune cells directly within patients to treat cancers, autoimmunity, and fibrosis, using a scalable mRNA-LNP platform for multi-lineage immune programming.
Explore CREATE Medicines's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.